Connect with us

Health

New Alzheimer’s treatment accelerates removal of plaque from the brain in clinical trials

Published

on

New Alzheimer’s treatment accelerates removal of plaque from the brain in clinical trials

Read this article for free!

Plus get unlimited access to thousands of articles, videos and more with your free account!

Please enter a valid email address.

By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

A new Alzheimer’s therapy has shown potential in the first human trials.

Researchers at the West Virginia University Rockefeller Neuroscience Institute (RNI) found that by pairing focused ultrasound in combination with antibody therapies, they were able to accelerate the removal of amyloid-beta plaques from the brains of patients with Alzheimer’s disease.

Advertisement

The study findings were published in The New England Journal of Medicine on Jan. 11.

FASTING COULD REDUCE SIGNS OF ALZHEIMER’S DISEASE, STUDIES SUGGEST: ‘PROFOUND EFFECTS’

An abnormal buildup of amyloid-beta proteins is one of the hallmarks of Alzheimer’s, as these proteins clump together to form plaques that interfere with neurons in the brain. 

Anti-amyloid-beta monoclonal antibody treatments, such as aducanumab and lecanemab, have proven to be effective in clearing these plaques and slowing disease progression.

An Alzheimer’s patient undergoes focused ultrasound treatment with the WVU RNI team. (Rockefeller Neuroscience Institute (RNI) at West Virginia University (WVU))

Advertisement

But until now the drugs have been limited by the blood-brain barrier (BBB), which is designed to keep harmful substances from reaching the brain, according to a press release from RNI.

“A study like this is important because it demonstrates that there may be safe ways to increase drug delivery to the brain without any serious adverse effects.”

More than 98% of drugs are blocked by the barrier, which means patients require higher doses and more frequent therapies, the researchers noted.

ALZHEIMER’S BLOOD TEST COULD HIT THE MARKET IN EARLY 2024, RESEARCHERS SAY

In this study, scientists used a focused ultrasound (FUS) system to temporarily open the blood-brain barrier, which allowed the antibodies to have greater access to areas of the brain with high amyloid-beta plaques.

Advertisement

After six months of antibody treatment, the study participants had an average of 32% more reduction in amyloid-beta plaques in areas where the BBB was opened compared to areas where the drug was used without the ultrasound, the release stated.

The WVU RNI team, shown in the MRI suite’s control area, plans ultrasound blood-brain barrier treatment. (Rockefeller Neuroscience Institute (RNI) at West Virginia University (WVU))

“This was a first in human safety and feasibility study in three participants demonstrating that the BBB opening can accelerate clearance of beta amyloid plaques,” study lead Dr. Ali Rezai, director of the Rockefeller Neuroscience Institute (RNI) at WVU, told Fox News Digital. 

“Non-invasive focused ultrasound is an outpatient procedure that allows for targeted delivery of therapeutics to the brain that can potentially accelerate the benefit of the antibody treatment in Alzheimer’s disease,” he added.

DEMENTIA AMONG YOUNGER PEOPLE IS LINKED TO 15 FACTORS, MAJOR STUDY REVEALS

Advertisement

The three patients, between the ages of 59 and 77, all had mild Alzheimer’s disease.

During the study, they received six monthly infusions of the aducanumab antibody. 

After each treatment, the focused ultrasound was used to open the BBB at the sites of the highest plaque buildup.

While there are some potential risks associated with ultrasound use, such as brain swelling and hemorrhage, Rezai said those effects were not observed in this study.

The focused ultrasound helmet unit with 1,024 ultrasound transducers attaches to the MRI table for MRI-guided treatment. (Rockefeller Neuroscience Institute (RNI) at West Virginia University (WVU))

Advertisement

“We verified with MRI scans that the BBB opening was temporary and it closed 24 to 48 hours after the FUS procedure,” he told Fox News Digital.

The reductions in amyloid plaques were verified in PET scans.

SMOKING SHRINKS THE BRAIN AND DRIVES UP ALZHEIMER’S RISK, NEW STUDY FINDS

This was the first step toward larger studies; in those, researchers will be able to evaluate more patients and larger areas of the brain, Rezai noted.

In the next phase of the clinical trial, the ultrasound therapy will be paired with lecanemab, another anti-beta amyloid antibody.

Advertisement

This 3-D illustration shows how ultrasound waves from inside the helmet converge on a focal point on the brain used for blood-brain barrier opening.  (Rockefeller Neuroscience Institute (RNI) at West Virginia University (WVU))

Dr. James Galvin, director of the Comprehensive Center for Brain Health at UHealth, the University of Miami Health System, was not involved in the WVU research but shared his reaction.

“A study like this is important because it demonstrates that there may be safe ways to increase drug delivery to the brain without any serious adverse effects,” he told Fox News Digital. 

DEMENTIA’S STAGGERING FINANCIAL COST IS REVEALED IN NEW REPORT: IT’S ‘BANKRUPTING FAMILIES’

“Focused ultrasound has been used in other treatment paradigms for brain diseases such as Parkinson’s disease and brain tumors,” Galvin went on. 

Advertisement

Galvin also cautioned that this research was conducted with only three patients and was not a placebo-controlled study. 

As of 2023, an estimated 6.7 million Americans age 65 and older were living with Alzheimer’s. (iStock)

“It was also designed as a safety study and not appropriately powered to detect significant clinical changes,” he added. “It is still too early to make any specific recommendations, but I am excited to see if there are planned follow-up studies with a larger number of patients.”

Rebecca M. Edelmayer, PhD, senior director of scientific engagement at the Alzheimer’s Association, was also not involved in the study but called the results “very intriguing,” albeit preliminary.

“The blood brain barrier, in its healthy form, protects the brain from harmful agents that could reach it via the bloodstream,” she told Fox News Digital via email.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Getting therapeutics across this barrier — from the bloodstream into the brain tissue — is a challenge for any drug used to treat brain diseases, including drugs to treat Alzheimer’s disease.”

Edelmayer added that while this was a “very small study of relatively short length,” it was a worthwhile way to test a “cutting-edge idea” for improving the effectiveness of Alzheimer’s medications.

This illustration of the MRI-guided focused ultrasound system includes a representation of treatment delivery, the target region, and the corresponding opening of the blood-brain barrier demonstrated by contrast enhancement. (Rockefeller Neuroscience Institute (RNI) at West Virginia University (WVU))

Focused ultrasound-induced blood-brain barrier opening has also been shown to improve drug delivery to treat brain tumors, Edelmayer pointed out. 

Advertisement

“This is a great example of how learnings from research in other diseases might be repurposed for Alzheimer’s disease and other dementia.”

Looking ahead, Edelmayer said the results of this early research point to the need for larger-scale, longer trials.

“We need more research in individuals with Alzheimer’s disease from all communities to know the full impact this approach could have.”

For more Health articles, visit www.foxnews.com/health

Advertisement

Health

GLP-1s Don’t Work for Everyone: What To Know if You’re Not Seeing Results

Published

on

GLP-1s Don’t Work for Everyone: What To Know if You’re Not Seeing Results


Advertisement





GLP-1 Not Working? Here’s Why and Alternatives That Can Help




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Common eating habit may trigger premature immune system aging, study finds

Published

on

Common eating habit may trigger premature immune system aging, study finds

NEWYou can now listen to Fox News articles!

Eating too much salt has long been linked to high blood pressure, but new research suggests it could trick the immune system into prematurely aging the blood vessels.

A preclinical study recently published in the Journal of the American Heart Association has identified a biological chain reaction that links a salty diet to cardiovascular decay.

Scientists at the University of South Alabama observed that mice on a high-salt diet experienced rapid deterioration in their blood vessel function.

HIGH SALT INTAKE LINKED TO FASTER MEMORY DECLINE IN ONE GROUP, STUDY FINDS

Advertisement

After just four weeks of high sodium intake, the small arteries responsible for regulating blood flow lost their ability to relax, according to a press release.

The team found that the cells lining these vessels had entered a state of cellular senescence, a form of premature cellular aging in which cells stop dividing and release a mix of inflammatory signals that can damage surrounding tissue.

Excess salt has long been linked to high blood pressure, but a new study goes deeper into its effects on the cardiovascular system. (iStock)

The researchers tried to replicate this damage by exposing blood vessel cells directly to salt in a laboratory dish, but the cells showed no harmful effects.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

This suggests that salt isn’t directly causing damage to the vascular lining but that the real culprit may be the body’s own defense mechanism, the researchers noted.

Excess salt may trigger the immune system to release a molecule called interleukin-16 (IL-16), which acts as a messenger that instructs blood vessel cells to grow old before their time, according to the study.

Excess salt may trigger the immune system to release a molecule called interleukin-16, which acts as a messenger that instructs blood vessel cells to grow old before their time, according to the study. (iStock)

Once these cells age, they fail to produce nitric oxide, the essential gas that tells arteries to dilate and stay flexible.

To test whether this process could be reversed, the team turned to a class of experimental drugs known as senolytics.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Using a cancer medication called navitoclax, which selectively clears out aged and dysfunctional cells, the researchers were able to restore nearly normal blood vessel function in the salt-fed mice, the release stated.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ.

By removing the decaying cells created by the high-salt diet, the drug allowed the remaining healthy tissue to maintain its elasticity and respond correctly to blood flow demands.

Excess salt may trigger the immune system into stopping the cells from dividing, the study suggests. (iStock)

Advertisement

The study did have some limitations. The transition from mouse models to human treatment remains a significant hurdle, the team cautioned.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Senolytic drugs like navitoclax are still being studied for safety, and the team emphasized that previous trials have shown mixed results regarding their impact on artery plaque.

Additionally, the researchers have not yet confirmed whether the same IL-16 pathway is the primary driver of vascular aging in humans.

Advertisement
Continue Reading

Health

Healthy diets spark lung cancer risk in non-smokers as pesticides loom

Published

on

Healthy diets spark lung cancer risk in non-smokers as pesticides loom

NEWYou can now listen to Fox News articles!

Eating a diet high in fruits and vegetables was found to have a surprising link to lung cancer among younger non-smokers, early research suggests.

The observational study, led by Jorge Nieva, M.D., of the USC Norris Comprehensive Cancer Center at Keck Medicine, was presented this month at the American Association for Cancer Research (AACR) annual meeting in San Diego. It has not yet been peer-reviewed. 

Researchers looked at dietary, smoking and demographic data for 187 patients who were diagnosed with lung cancer at age 50 or younger. 

PANCREATIC CANCER PATIENT SURVIVAL DOUBLED WITH HIGH DOSE OF COMMON VITAMIN, STUDY FINDS

Advertisement

They found that among non-smokers, there was a link between healthier-than-average diets – rich in fruits, vegetables and whole grains – and the chance of lung cancer development.

Young lung cancer patients ate more servings of dark green vegetables, legumes and whole grains compared to the average U.S. adult, the researchers found.

Eating a diet high in fruits and vegetables was found to have a surprising link to lung cancer among younger non-smokers, early research suggests. (iStock)

The researchers hypothesized that pesticides applied to conventionally grown produce could be a possible factor in the disease association.

“Commercially produced (non-organic) fruits, vegetables and whole grains are more likely to be associated with a higher residue of pesticides than dairy, meat and many processed foods,” according to Nieva. He also noted that agricultural workers exposed to pesticides tend to have higher rates of lung cancer.

Advertisement

HIDDEN VIRUS INSIDE GUT BACTERIA LINKED TO DOUBLED COLORECTAL CANCER RISK, STUDY FINDS

“There is a large subset of lung cancer patients whose disease is not caused by smoking,” Nieva told Fox News Digital.

The disease is becoming more common in non-smokers 50 and younger, especially women – despite the fact that smoking rates have been falling for decades, the researcher noted.

The researchers hypothesized that pesticides applied to conventionally grown produce could be a possible factor in the disease association. (iStock)

“These patients tend to have eaten much healthier diets before their diagnosis than the average American,” he went on. “We need to support research into understanding why Americans – and women in particular – who no longer smoke very much are still having lung cancer,” he said.

Advertisement

DEATHS FROM ONE TYPE OF CANCER ARE SURGING AMONG YOUNGER ADULTS WITHOUT COLLEGE DEGREES

The study did have some limitations, Nieva acknowledged, primarily that it relied on survey data and was limited by the participants’ memories of their food intake.  

“Also, the survey participants were self-selected, and this could have biased the findings,” he told Fox News Digital.

“There is a large subset of lung cancer patients whose disease is not caused by smoking.”

The researchers did not test specific foods for pesticides, relying instead on average pesticide levels for certain types of food. Looking ahead, they plan to test patients’ blood and urine samples to directly measure pesticide levels, Nieva said.

Advertisement

Although the study shows only an association and does not prove that pesticides caused lung cancer, Nieva recommends that people wash their produce before eating and choose organic foods whenever possible.

CLICK HERE FOR MORE HEALTH STORIES

“This work represents a critical step toward identifying modifiable environmental factors that may contribute to lung cancer in young adults,” said Nieva. “Our hope is that these insights can guide both public health recommendations and future investigation into lung cancer prevention.”  

“It is possible that the increased lung cancer risk could be due to pesticide exposure in whole farmed foods, but is by no means certain,” a doctor said. (AP Photo/Charlie Neibergall)

Dr. Marc Siegel, Fox News senior medical analyst, said the study is “interesting,” but that it “raises far more questions than it answers.”

Advertisement

“It is a small study (around 150) and observational, so no proof,” the doctor, who was not involved in the research, told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“It is possible that the increased lung cancer risk could be due to pesticide exposure in whole farmed foods, but it is by no means certain,” Siegel went on. “How much exposure is needed? How much of it gets into food and in which areas? This requires much further study.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Kayla Nichols, communications director for Pesticide Action & Agroecology Network, a distributed global network, said the organization agrees with the study’s conclusion that more research should be done on the rise in lung cancer, particularly in individuals eating diets higher in produce and fiber.

Advertisement

“There is a large subset of lung cancer patients whose disease is not caused by smoking,” the researcher told Fox News Digital. (iStock)

“There is a bounty of existing research that already links pesticide exposure to increased risk of multiple types of cancers,” Nichols, who was also not involved in the study, told Fox News Digital. She called for more research on chronic, low-level exposures to pesticides, as well as more effective policies to protect the public from pesticide residues on food.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was supported by the National Institutes of Health and the National Cancer Institute, as well as industry partners including AstraZeneca and Genentech, among others.

Fox News Digital reached out to several pesticide companies and trade groups for comment.

Advertisement

Continue Reading
Advertisement

Trending